WHO: Europe Must Accelerate Adoption of AI in Hospitals

Key Takeaways

AI tools are transforming healthcare in Europe, but regulatory frameworks are lagging.
Only 8% of WHO European countries have a health-specific AI strategy, posing risks to patient safety.
Public trust in healthcare is eroding due to the lack of ethical guidelines and education on AI use.

AI’s Impact on Healthcare

Artificial intelligence is significantly enhancing healthcare systems across Europe, providing innovative diagnostic tools and streamlining workflows. Despite the benefits, Hans Henri P. Kluge, the World Health Organization (WHO) Europe chief, emphasized a critical challenge: the regulatory frameworks for these technologies are inadequate or nonexistent in many countries.

During a press conference in Lisbon on July 15, Kluge highlighted the concerning gap between AI deployment and governance. “That gap — between deployment and governance — is the defining challenge of AI in health right now,” he stated. This lack of oversight raises alarm bells about patient safety. Kluge warned that “a biased algorithm can produce a wrong diagnosis, for a real patient, with real consequences,” underscoring the urgent need for regulations.

Currently, two-thirds of the 53 WHO European countries are already utilizing AI diagnostics, and half have implemented AI-driven patient chatbots. However, only one in twelve countries has developed a comprehensive strategy for governing AI technologies within health systems. Alarmingly, only 8% of countries in the WHO European Region have a dedicated health-specific AI strategy. Furthermore, nearly 40% of the countries lack any ethical guidance on the use of AI in healthcare.

Educational initiatives are also underperforming: only one in five nations provides AI training for healthcare students, and a mere one in four offers ongoing training once professionals enter the workforce. Kluge described this situation as “concerning,” stressing that it could adversely affect human health. He cautioned that the lack of regulation and education not only hampers the effectiveness of AI tools but also erodes public trust in health systems as a whole.

To address these challenges, WHO aims to introduce a Roadmap on AI and Health by 2028, which will likely focus on establishing necessary regulations and ethical guidelines. This initiative is crucial for ensuring that AI technologies in healthcare can be safely implemented while maintaining public confidence in medical systems. The stakes are high, and timely action is essential for safeguarding patient safety and enhancing the effectiveness of healthcare services in Europe.

The content above is a summary. For more details, see the source article.